Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...

There is a significant unmet need for additional treatment options for high-grade NMIBC, especially in those ineligible for BCG.

Wacky doctors like Gregory House only look and sound cool on paper and the television screen. In reality, dealing with a rude ...

IVDs are essential for disease detection, personalized treatment, and public health, driving growth in the global diagnostics ...

Pfizer enters the new year as a company in transition, but one with a heavily fortified bottom line. Management has set a revenue floor of approximately $61 billion for 2026. This is a realistic, ...

About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

A GP-focused pelvic and women’s health clinic developed in Tasmania has revolutionised the way rural women access health ...

The issues concerning the hormone balance have a great impact on the general well-being, the level of energy, the mood ...